Opening Hours : Monday to Friday: 8am - 6pm | Sat & Sun: CLOSED
4683 Log Cabin Dr. | Macon, GA 31204 4683 Log Cabin Dr. Macon, GA 31204
Contact (478) 812-8980 (478) 812-8980
Photo by freestocks.org from Pexels
Medicine Lookup
Medical News
Drugs.com – Daily MedNews
- Gene Test Can Predict Breast Cancer Risk For Women Diagnosed With Abnormal CellsTHURSDAY, Oct. 2, 2025 — A genetic risk score can help predict which women will develop invasive breast cancer after abnormal cells have been found in their breast tissue, researchers said.Women who scored high on the genetic blood test were twice a...
- Industrial Chemical Linked To Parkinson's DiseaseTHURSDAY, Oct. 2, 2025 — Long-term exposure to a chemical used in metal degreasing and dry cleaning might increase the risk of Parkinson’s disease, a new study says.Seniors living in places with the highest airborne levels of trichloroethylene sho...
- Adrenaline Nasal Sprays Work As Well As EpiPen For Allergic ShockTHURSDAY, Oct. 2, 2025 — People with extreme, life-threatening allergic reactions might do as well to use a nasal spray as jab themselves in a thigh with an EpiPen, a new evidence review says.Adrenaline delivered with liquid or powder nasal sprays i...
Headline News
Drugs.com – News for Health Professionals
- Cancer Survival Lower in Rural AreasWEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White individuals in the United States, according to a study published online...
- Telestroke Tied to Higher Odds of Thrombolysis TreatmentWEDNESDAY, Oct. 1, 2025 -- Patients with acute ischemic stroke evaluated using telemedicine have higher odds of receiving thrombolysis treatment, but it takes them significantly longer to be treated, according to a study published online Sept. 26 in...
- Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor AgonistsWEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according...
FDA Alerts
Drugs.com – FDA MedWatch Alerts
- FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)Audience: Patient, Pharmacy, Health Care Professional September 25, 2025 -- The U.S. Food and Drug Administration today removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication...
- FDA Removes Risk Evaluation and Mitigation Strategy (REMS) Program for the Antipsychotic Drug ClozapineAudience: Patient, Pharmacy, Health Care Professional August 27, 2025 -- FDA Removes Risk Evaluation and Mitigation Strategies (REMS) Program for the Antipsychotic Drug Clozapine Neutropenia Risk Remains, but REMS No Longer Necessary and REMS May...
- Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to MislabelingAudience: Consumer, Pharmacy, Health Care Professional August 27, 2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level. The...